RIP140 regulates transcription factor HES1 oscillatory expression and mitogenic activity in colon cancer cells

Archive ouverte

Sfeir, Nour | Kajdan, Marilyn | Jalaguier, Stéphan | Bonnet, Sandrine | Teyssier, Catherine | Pyrdziak, Samuel | Yuan, Rong | Bousquet, Emilie | Maraver, Antonio | Bernex, Florence | Pirot, Nelly | Boissière-Michot, Florence | Castet-Nicolas, Audrey | Lapierre, Marion | Cavaillès, Vincent

Edité par CCSD ; FEBS Press -

International audience. The transcription factor receptor‐interacting protein 140 (RIP140) regulates intestinal homeostasis and tumorigenesis through Wnt signaling. In this study, we investigated its effect on the Notch/HES1 signaling pathway. In colorectal cancer (CRC) cell lines, RIP140 positively regulated HES1 gene expression at the transcriptional level via a recombining binding protein suppressor of hairless (RBPJ)/neurogenic locus notch homolog protein 1 (NICD)‐mediated mechanism. In support of these in vitro data, RIP140 and HES1 expression significantly correlated in mouse intestine and in a cohort of CRC samples, thus supporting the positive regulation of HES1 gene expression by RIP140. Interestingly, when the Notch pathway is fully activated, RIP140 exerted a strong inhibition of HES1 gene transcription controlled by the level of HES1 itself. Moreover, RIP140 directly interacts with HES1 and reversed its mitogenic activity in human CRC cells. In line with this observation, HES1 levels were associated with a better patient survival only when tumors expressed high levels of RIP140. Our data identify RIP140 as a key regulator of the Notch/HES1 signaling pathway, with a dual effect on HES1 gene expression at the transcriptional level and a strong impact on colon cancer cell proliferation.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion